Viewing Study NCT07189468


Ignite Creation Date: 2025-12-24 @ 5:43 PM
Ignite Modification Date: 2025-12-30 @ 9:07 AM
Study NCT ID: NCT07189468
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-24
First Post: 2025-09-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: AI-based Progression and Medication Response Prediction Study in Parkinson's Disease
Sponsor: University Hospital, Toulouse
Organization:

Study Overview

Official Title: AI-based Progression and Medication Response Prediction Study in Parkinson's Disease
Status: NOT_YET_RECRUITING
Status Verified Date: 2025-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: AI-PMP
Brief Summary: The study aims to provide initial PoC validation data of two AI models to predict disease progression and treatment side effects in PD patients using as input patients' demographic, clinical and genetic information, as well as digital biomarker measurements in daily living collected via a smartwatch and a mobile application.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: